Campuzano ZG, Blair TS

Language: Spanish
References: 171
Page: 311-354
PDF size: 2240.31 Kb.

ABSTRACT

Malaria has afflicted the human species for millennia and continues to be one of the diseases that cause high morbidity and mortality, particularly in tropical areas in developing countries. Malaria is the most important parasitic infection, accounting for more than a million deaths per year worldwide. Malaria is caused by one of the four species of Plasmodium that infect humans: P. vivax, P. ovale, P. malaria and P. falciparum, the latter posing the greater risk for patients due to its ability to infect erythrocytes of all ages, secuestration in microcirculation and its resistance to antimalarial drugs. Because of the increasing parasite resistance to antimalarial drugs and the increasing international travel, among other factors, the incidence of malaria continues to rise. This module describes the most important aspects of the parasite and the disease, including the life cycle, epidemiology and associated clinical manifestations. Finally, special emphasis is made on the various diagnostic tests, their indications and availability.

REFERENCES

1. World Health Organization. Malaria; Key facts. Vol. 2010. Geneva: WHO; 2010.

2. Lee KS, Cox-Singh J, Singh B. Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. Malar J 2009; 8: 73.

3. WHO. World malaria report 2009 (ed 3). Geneva: World Health Organization; 2009.

4. D’Acremont V, Lengeler C, Genton B. Stop ambiguous messages on malaria diagnosis. BMJ 2007; 334: 489.

5. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJ, et al. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ 2008; 336: 202-205.

6. Newman RD, Parise ME, Barber AM, Steketee RW. Malaria-related deaths among U.S. travelers, 1963-2001. Ann Intern Med 2004; 141: 547-555.

7. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-217.

8. Carter R, Mendis KN. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev 2002; 15: 564-594.

9. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, et al. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 2008; 5: e38.

10. Roll Back Malaria WHO, UNICEF. 2005. World malaria report 2005. http://rbm.who.int/wmr2005.

11. Xu WY. [Mechanism of protective immunity induced by irradiation-attenuated sporozoites and its implication for pre-erythrocytic malaria vaccine research]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2009; 27: 70-74.

12. Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 2009; 199: 899-903.

13. Robinson LJ, D’Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS, et al. Cellular tumor necrosis factor, gamma interferon, and interleukin- 6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 2009; 77: 3033-3043.

14. Roll Back Malaria. Key malaria facts; 2010.

15. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002; 415: 680-685.

16. Pan American Health Organization. PAHO Basic Health Indicator Data Base: Colombia. Vol. 2008: World Health Organization; 2003.

17. Pan American Health Organization. 2008. 142nd Session of the executive committee. http://www.paho.org/English/GOV/CE/ce14216-e.pdf.

18. Instituto Nacional de Salud. Boletín epidemiológico semana 51. In: Sivigila ed. Bogota: boletín epidemiológico semana 51 2009, ; 2009.

19. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet 2005; 365: 1487-1498.

20. Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell 2006; 124: 755-766.

21. Aly AS, Vaughan AM, Kappe SH. Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol 2009; 63: 195-221.

22. Centers for Disease Control and Prevention. Anopheles mosquitoes; 2010.

23. Organización Panamericana de Salud. Informe de la Situación del Paludismo en las Ámericas, Sección Colombia. Programa de Paludismo de Enfermedades Transmisibles; 2008.

24. Mabaso ML, Sharp B, Lengeler C. Historical review of malarial control in southern African with emphasis on the use of indoor residual house-spraying. Trop Med Int Health 2004; 9: 846-856.

25. Gatton ML, Cheng Q. Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals. Am J Trop Med Hyg 2002; 66: 467-473.

26. McGuire W, D’Alessandro U, Stephens S, Olaleye BO, Langerock P, Greenwood BM, et al. Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Trans R Soc Trop Med Hyg 1998; 92: 50-53.

27. Naik RS, Branch OH, Woods AS, Vijaykumar M, Perkins DJ, Nahlen BL, et al. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med 2000; 192: 1563-1576.

28. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 2003; 19: 188-193.

29. Blair-Trujillo S, Alvares G, Campuzano-Maya G. Relación entre anemia y malaria en una población rural de Colombia. Bolettn de la Direccion de Malariologia Y Saneamiento Ambiental 1997; 37.

30. Pongponratn E, Riganti M, Harinasuta T, Bunnag D. Electron microscopy of the human brain in cerebral malaria. Southeast Asian J Trop Med Public Health 1985; 16: 219-227.

31. Sherman IW, Eda S, Winograd E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect 2003; 5: 897-909.

32. Chotivanich KT, Dondorp AM, White NJ, Peters K, Vreeken J, Kager PA, et al. The resistance to physiological shear stresses of the erythrocytic rosettes formed by cells infected with Plasmodium falciparum. Ann Trop Med Parasitol 2000; 94: 219-226.

33. Dondorp AM, Nyanoti M, Kager PA, Mithwani S, Vreeken J, Marsh K. The role of reduced red cell deformability in the pathogenesis of severefalciparum malaria and its restoration by blood transfusion. Trans R Soc Trop Med Hyg 2002; 96: 282-286.

34. Higgins MK. The structure of a chondroitin sulfate-binding domain important in placental malaria. J Biol Chem 2008; 283: 21842-21846.

35. Chen Q, Fernandez V, Sundstrom A, Schlichtherle M, Datta S, Hagblom P, et al. Developmental selection of var gene expression in Plasmodium falciparum. Nature 1998; 394: 392-395.

36. Yipp BG, Anand S, Schollaardt T, Patel KD, Looareesuwan S, Ho M. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood 2000; 96: 2292-2298.

37. Fairhurst RM, Wellems TE. Plasmodium Species (Malaria) In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol. 2 (ed 6): Churchill Livingstone; 2005.

38. Reeder JC, Cowman AF, Davern KM, Beeson JG, Thompson JK, Rogerson SJ, et al. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. Proc Natl Acad Sci U S A 1999; 96: 51985202.

39. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, Buley ID, et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994; 145: 1057-1069.

40. Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 1997; 57: 389-398.

41. Chen Q, Barragan A, Fernandez V, Sundstrom A, Schlichtherle M, Sahlen A, et al. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med 1998; 187: 15-23.

42. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 1995; 82: 77-87.

43. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 1995; 82: 89-100.

44. Scherf A, Lopez-Rubio JJ, Riviere L. Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol 2008; 62: 445-470.

45. Hemmer CJ, Vogt A, Unverricht M, Krause R, Lademann M, Reisinger EC. Malaria and bacterial sepsis: similar mechanisms of endothelial apoptosis and its prevention in vitro. Crit Care Med 2008; 36: 2562-2568.

46. WHO. The role of laboratory diagnosis to support malaria disease management. Report of a WHO technical Consultation. Geneva; 2006: 5-6.

47. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5: 722-735.

48. World Health Organization. Parasitological confirmation of malaria diagnosis. Geneva; 2009.

49. Tobon A. [Danger signs in the malaria patient]. Biomedica 2009; 29: 320-329.

50. Cogswell FB. The hypnozoite and relapse in primate malaria. Clin Microbiol Rev 1992; 5: 26-35.

51. Pongponratn E, Viriyavejakul P, Wilairatana P, Ferguson D, Chaisri U, Turner G, et al. Absence of knobs on parasitized red blood cells in a splenectomized patient in fatal falciparum malaria. Southeast Asian J Trop Med Public Health 2000; 31: 829-835.

52. Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria--implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349: 1510-1516.

53. Krotoski WA, Collins WE, Bray RS, Garnham PC, Cogswell FB, Gwadz RW, et al. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg 1982; 31: 1291-1293.

54. Nishiura H, Lee HW, Cho SH, Lee WG, In TS, Moon SU, et al. Estimates of short- and longterm incubation periods of Plasmodium vivax malaria in the Republic of Korea. Trans R Soc Trop Med Hyg 2007; 101: 338-343.

55. Tsuchida H, Yamaguchi K, Yamamoto S, Ebisawa I. Quartan malaria following splenectomy 36 years after infection. Am J Trop Med Hyg 1982; 31: 163-165.

56. Thang HD, Elsas RM, Veenstra J. Airport malaria: report of a case and a brief review of the literature. Neth J Med 2002; 60: 441-443.

57. Kockaerts Y, Vanhees S, Knockaert DC, Verhaegen J, Lontie M, Peetermans WE. Imported malaria in the 1990s: a review of 101 patients. Eur J Emerg Med 2001; 8: 287-290.

58. Oh MD, Shin H, Shin D, Kim U, Lee S, Kim N, et al. Clinical features of vivax malaria. Am J Trop Med Hyg 2001; 65: 143-146.

59. Hanscheid T, Pinto BG, Pereira I, Cristino JM, Valadas E. Avoiding misdiagnosis of malaria: a novel automated method allows specific diagnosis, even in the absence of clinical suspicion. Emerg Infect Dis 1999; 5: 836-838.

60. Campuzano-Zuluaga G, Alvarez-Sanchez G, Escobar-Gallo GE, Valencia-Zuluaga LM, Rios- Orrego AM, Pabon-Vidal A, et al. Design of malaria diagnostic criteria for the Sysmex XE2100 hematology analyzer. Am J Trop Med Hyg 2010; 82: 402-411.

61. Chotivanich K, Udomsangpetch R, Simpson JA, Newton P, Pukrittayakamee S, Looareesuwan S, et al. Parasite multiplication potential and the severity of Falciparum malaria. J Infect Dis 2000; 181: 1206-1209.

62. Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 2006; 75: 790-797.

63. Simpson JA, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ. Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Trans R Soc Trop Med Hyg 1999; 93: 165-168.

64. Amodu OK, Adeyemo AA, Olumese PE, Gbadegesin RA. Intraleucocytic malaria pigment and clinical severity of malaria in children. Trans R Soc Trop Med Hyg 1998; 92: 54-56.

65. Rogerson SJ, Carter R. Severe vivax malaria: newly recognised or rediscovered. PLoS Med 2008; 5: e136.

66. WHO. Guidelines for the treatment of malaria. (ed 2). Geneva: World Health Organization; 2010.

67. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94: 1-90.

68. Ministerio de la Protección Social República de Colombia. Guía 19. Guía de atención de la malaria. In: pública Guías de Promoción de la Salud y Prevención de Enfermedades en la Salud Pública. Resolución 412, del año 2000. Bogota DC; 2005.

69. Carlini ME, White AC, Jr., Atmar RL. Vivax malaria complicated by adult respiratory distress syndrome. Clin Infect Dis 1999; 28: 11821183.

70. Oscherwitz SL. Chronic malaria with splenic rupture. J Travel Med 2003; 10: 64-65.

71. Okoro BA, Okafor HU, Nnoli LU. Childhood nephrotic syndrome in Enugu, Nigeria. West Afr J Med 2000; 19: 137-141.

72. Abdurrahman MB, Aikhionbare HA, Babaoye FA, Sathiakumar N, Narayana PT. Clinicopathological features of childhood nephrotic syndrome in northern Nigeria. Q J Med 1990; 75: 563-576.

73. Cunha CB, Cunha BA. Brief history of the clinical diagnosis of malaria: from Hippocrates to Osler. J Vector Borne Dis 2008; 45: 194-199.

74. Casalino E, Le Bras J, Chaussin F, Fichelle A, Bouvet E. Predictive factors of malaria in travelers to areas where malaria is endemic. Arch Intern Med 2002; 162: 1625-1630.

75. Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998; 27: 142-149.

76. Spitler DK. Malaria relapse; report of a case 36 years after original infection. N Engl J Med 1948; 238: 839.

77. Coatney GR. Relapse in malaria--an enigma. J Parasitol 1976; 62: 3-9.

78. Molyneux M, Fox R. Diagnosis and treatment of malaria in Britain. BMJ 1993; 306: 1175-1180.

79. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, Chierakul W, Simpson J, Looareesuwan S, et al. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood 2002; 100: 1172-1176.

80. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001; 414: 305-308.

81. Bank A. The thalassemia syndromes. Blood 1978; 51: 369-384.

82. Oppenheimer SJ, Hill AV, Gibson FD, Macfarlane SB, Moody JB, Pringle J. The interaction of alpha thalassaemia with malaria. Trans R Soc Trop Med Hyg 1987; 81: 322-326.

83. Senok AC, Nelson EA, Li K, Oppenheimer SJ. Thalassaemia trait, red blood cell age and oxidant stress: effects on Plasmodium falciparum growth and sensitivity to artemisinin. Trans R Soc Trop Med Hyg 1997; 91: 585-589.

84. Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G. Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. Immunol Lett 1991; 30: 233-240.

85. Shear HL, Grinberg L, Gilman J, Fabry ME, Stamatoyannopoulos G, Goldberg DE, et al. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 1998; 92: 2520-2526.

86. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-249.

87. Golenser J, Miller J, Spira DT, Kosower NS, Vande Waa JA, Jensen JB. Inhibition of the intraerythrocytic development of Plasmodium falciparum in glucose-6-phosphate dehydrogenase deficient erythrocytes is enhanced by oxidants and by crisis form factor. Trop Med Parasitol 1988; 39: 273-276.

88. Foo LC, Rekhraj V, Chiang GL, Mak JW. Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines. Am J Trop Med Hyg 1992; 47: 271-275.

89. Pabon A, Carmona J, Burgos LC, Blair S. Oxidative stress in patients with non-complicated malaria. Clin Biochem 2003; 36: 71-78.

90. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261: 1182-1184.

91. Welch SG, McGregor IA, Williams K. The Duffy blood group and malaria prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg 1977; 71: 295-296.

92. WHO. Towards quality testing of malaria rapid diagnostic tests: evidence and methods, 2006.

93. World Health Organization. The use of malaria rapid diagnostic test (ed Second). Geneva: World Health Organization 2006.

94. Fleischer B. Editorial: 100 years ago: Giemsa’s solution for staining of plasmodia. Trop Med Int Health 2004; 9: 755-756.

95. Laveran A. Deuxième note relative a un nouveau parasite trouvé dans le sang des malades atteints de la fievre paludisme. Bulletin de l’Academie medicale 1880; 2: 1346-1347.

96. Shute GT, Sodeman TM. Identification of malaria parasites by fluorescence microscopy and acridine orange staining. Bull World Health Organ 1973; 48: 591-596.

97. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 2007; 77: 119-127.

98. Bain B, Chiodini P, England J, Bailey J. The laboratory diagnosis of malaria. Clin Lab Haem 1997; 19: 165-170.

99. Lema OE, Carter JY, Nagelkerke N, Wangai MW, Kitenge P, Gikunda SM, et al. Comparison of five methods of malaria detection in the outpatient setting. Am J Trop Med Hyg 1999; 60: 177-182.

100. Gutman JD, Kotton CN, Kratz A. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2003. A 60-year-old man with fever, rigors, and sweats. N Engl J Med 2003; 349: 1168-1175.

101. Centers for Disease Control & Prevention (CDC). Comparison of Plasmodium Species Which Cause Malaria in Humans. DPDx - Laboratory Identification of Parasites of Public Health Concern. Vol. 2010. Atlanta: CDC; 2009.

102. Nguyen PH, Day N, Pram TD, Ferguson DJ, White NJ. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 1995; 89: 200-204.

103. Day NP, Pham TD, Phan TL, Dinh XS, Pham PL, Ly VC, et al. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Blood 1996; 88: 4694-4700.

104. Lopez ML, Arango EM, Arias LR, Carmona- Fonseca J, Blair S. Hemozoina intraleucocitaria como indicador de malaria complicada por plasmodiumfalciparum. Acta Med Colomb 2004; 29: 80-87.

105. Lyke KE, Diallo DA, Dicko A, Kone A, Coulibaly D, Guindo A, et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg 2003; 69: 253-259.

106. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15: 66-78.

107. Beadle C, Long GW, Weiss WR, McElroy PD, Maret SM, Oloo AJ, et al. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 1994; 343: 564-568.

108. Humar A, Ohrt C, Harrington MA, Pillai D, Kain KC. Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. Am J Trop Med Hyg 1997; 56: 44-48.

109. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol 2006; 44: 2773-2778.

110. Pabon A, Alvarez G, Yanez J, Cespedes C, Rodriguez Y, Restrepo A, et al. [Evaluation of ICT malaria immunochromatographic Binax NOW ICT P.f/P.v test for rapid diagnosis of malaria in a Colombian endemic area]. Biomedica 2007; 27: 225-235.

111. Laferi H, Kandel K, Pichler H. False positive dipstick test for malaria. N Engl J Med 1997; 337: 1635-1636.

112. Singh N, Valecha N, Sharma VP. Malaria diagnosis by field workers using an immunochromatographic test. Trans R Soc Trop Med Hyg 1997; 91: 396-397.

113. Piper R, Lebras J, Wentworth L, Hunt-Cooke A, Houze S, Chiodini P, et al. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am J Trop Med Hyg 1999; 60: 109-118.

114. Londono B, Carmona J, Blair S. [Comparison between OptiMAL and the thick smear tests for malaria diagnosis in an endemic area during a non-epidemic period]. Biomedica 2002; 22: 466-475.

115. Palmer CJ, Lindo JF, Klaskala WI, Quesada JA, Kaminsky R, Baum MK, et al. Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria. J Clin Microbiol 1998; 36: 203-206.

116. Tjitra E, Suprianto S, Dyer M, Currie BJ, Anstey NM. Field evaluation of the ICT malaria P.f/P.v immunochromatographic test for detection of Plasmodium falciparum and Plasmodium vivax in patients with a presumptive clinical diagnosis of malaria in eastern Indonesia. J Clin Microbiol 1999; 37: 2412-2417.

117. Eisen DP, Saul A. Disappearance of pan-malarial antigen reactivity using the ICT Malaria P.f/P.v kit parallels decline of patent parasitaemia as shown by microscopy. Trans R Soc Trop Med Hyg 2000; 94: 169-170.

118. Makler MT, Ries LK, Ries J, Horton RJ, Hinrichs DJ. Detection of Plasmodium falciparum infection with the fluorescent dye, benzothiocarboxypurine. Am J Trop Med Hyg 1991; 44: 11-16.

119. Caramello P, Lucchini A, Savoia D, Gioannini P. Rapid diagnosis of malaria by use of fluorescent probes. Diagn Microbiol Infect Dis 1993; 17: 293-297.

120. Mayxay M, Pukrittayakamee S, Newton PN, White NJ. Mixed-species malaria infections in humans. Trends Parasitol 2004; 20: 233-240.

121. Guy R, Liu P, Pennefather P, Crandall I. The use of fluorescence enhancement to improve the microscopic diagnosis of falciparum malaria. Malar J 2007; 6: 89.

122. Pinto MJ, Rodrigues SR, Desouza R, Verenkar MP. Usefulness of quantitative buffy coat blood parasite detection system in diagnosis of malaria. Indian J Med Microbiol 2001; 19: 219-221.

123. Delacollette C, Van der Stuyft P. Direct acridine orange staining is not a ‘miracle’ solution to the problem of malaria diagnosis in the field. Trans R Soc Trop Med Hyg 1994; 88: 187-188.

124. Wongsrichanalai C, Pornsilapatip J, Namsiripongpun V, Webster HK, Luccini A, Pansamdang P, et al. Acridine orange fluorescent microscopy and the detection of malaria in populations with low-density parasitemia. Am J Trop Med Hyg 1991; 44: 17-20.

125. Gaye O, Diouf M, Diallo S. A comparison of thick smears, QBC malaria, PCR and PATH falciparum malaria test trip in Plasmodium falciparum diagnosis. Parasite 1999; 6: 273-275.

126. Grobusch MP, Hanscheid T, Kramer B, Neukammer J, May J, Seybold J, et al. Sensitivity of hemozoin detection by automated flow cytometry in non- and semi-immune malaria patients. Cytometry B Clin Cytom 2003; 55: 46-51.

127. Seed CR, Kitchen A, Davis TM. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev 2005; 19: 229-240.

128. Doderer C, Heschung A, Guntz P, Cazenave JP, Hansmann Y, Senegas A, et al. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Malar J 2007; 6: 19.

129. Hanscheid T, Valadas E. Malaria diagnosis. Am J Trop Med Hyg 1999; 61: 179.

130. Mendelow BV, Coetzer TL. Automated malaria detection. Br J Haematol 1999; 106: 257-258.

131. Hanscheid T, Melo-Cristino J, Pinto BG. Automated detection of malaria pigment in white blood cells for the diagnosis of malaria in Portugal. Am J Trop Med Hyg 2001; 64: 290-292.

132. Wever PC, Henskens YM, Kager PA, Dankert J, van Gool T. Detection of imported malaria with the Cell-Dyn 4000 hematology analyzer. J Clin Microbiol 2002; 40: 4729-4731.

133. Fawzi ZO, Fakhro NA, Nabhan RA, Alloueche A, Scott CS. Differences in automated depolarization patterns of Plasmodium falciparum and P. vivax malaria infections defined by the Cell-Dyn CD4000 haematology analyser. Trans R Soc Trop Med Hyg 2003; 97: 71-79.

134. Scott CS, van Zyl D, Ho E, Meyersfeld D, Ruivo L, Mendelow BV, et al. Automated detection of malaria-associated intraleucocytic haemozoin by Cell-Dyn CD4000 depolarization analysis. Clin Lab Haematol 2003; 25: 77-86.

135. Suh IB, Kim HJ, Kim JY, Lee SW, An SS, Kim WJ, et al. Evaluation of the Abbott Cell-Dyn 4000 hematology analyzer for detection and therapeutic monitoring of Plasmodium vivax in the Republic of Korea. Trop Med Int Health 2003; 8: 1074-1081.

136. Dromigny JA, Jambou R, Scott CS, PerrierGros- Claude JD. Performance evaluation of automated depolarization analysis for detecting clinically unsuspected malaria in endemic countries. Trans R Soc Trop Med Hyg 2005; 99: 430439.

137. Josephine FP, Nissapatorn V. Malaria: the value of the automated depolarization analysis. Southeast Asian J Trop Med Public Health 2005; 36 Suppl 4: 68-72.

138. Padial MM, Subirats M, Puente S, Lago M, Crespo S, Palacios G, et al. Sensitivity of laser light depolarization analysis for detection of malaria in blood samples. J Med Microbiol 2005; 54: 449-452.

139. de Langen AJ, van Dillen J, de Witte P, Mucheto S, Nagelkerke N, Kager P. Automated detection of malaria pigment: feasibility for malaria diagnosing in an area with seasonal malaria in northern Namibia. Trop Med Int Health 2006; 11: 809-816.

140. Hanscheid T, Langin M, Lell B, Potschke M, Oyakhirome S, Kremsner PG, et al. Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity. Malar J 2008; 7: 109.

141. Hanscheid T, Langin M, Codices V, Luty AJ, Adegnika AA, Kremsner PG, et al. Automated detection of haemozoin-containing monocytes for the diagnosis of malaria in microscopically negative cases during pregnancy. Acta Trop 2009; 109: 245-246.

142. Rathod DA, Patel V, Kaur AA, Patel VD, Patel DD. Diagnosis of acute malaria by laser based cell counter with comparison of conventional and recent techniques in Indian scenario. Indian J Pathol Microbiol 2009; 52: 185-188.

143. Briggs C, Da Costa A, Freeman L, Aucamp I, Ngubeni B, Machin SJ. Development of an automated malaria discriminant factor using VCS technology. Am J Clin Pathol 2006; 126: 691698.

144. Fourcade C, Casbas MJ, Belaouni H, Gonzalez JJ, Garcia PJ, Pepio MA. Automated detection of malaria by means of the haematology analyser Coulter GEN.S. Clin Lab Haematol 2004; 26: 367-372.

145. Huh HJ, Oh GY, Huh JW, Chae SL. Malaria detection with the Sysmex XE-2100 hematology analyzer using pseudoeosinophilia and abnormal WBC scattergram. Ann Hematol 2008; 87: 755-759.

146. Yoo JH, Song J, Lee KA, Sun YK, Kim YA, Park TS, et al. Automated detection of malaria-associated pseudoeosinophilia and abnormal WBC scattergram by the Sysmex XE-2100 hematology analyzer: a clinical study with 1,801 patients and real-time quantitative PCR analysis in vivax malaria-endemic area. Am J Trop Med Hyg 2010; 82: 412-414.

147. Farcas GA, Soeller R, Zhong K, Zahirieh A, Kain KC. Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin Infect Dis 2006; 42: 622-627.

148. Scott CS, Van Zyl D, Ho E, Ruivo L, Kunz D, Coetzer TL. Patterns of pseudo-reticulocytosis in malaria: fluorescent analysis with the Cell- Dyn CD4000. Clin Lab Haematol 2002; 24: 1520.

149. Hanscheid T. Current strategies to avoid misdiagnosis of malaria. Clin Microbiol Infect 2003; 9: 497-504.

150. Hanscheid T, Grobusch MP. How useful is PCR in the diagnosis of malaria? Trends Parasitol 2002; 18: 395-398.

151. Ustianowski A, Schwab U, Pasvol G. Case report: severe acute symptomatic hyponatraemia in falciparum malaria. Trans R Soc Trop Med Hyg 2002; 96: 647-648.

152. Vander Jagt DL, Hunsaker LA, Campos NM, Baack BR. D-lactate production in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 1990; 42: 277-284.

153. Dekker E, Hellerstein MK, Romijn JA, Neese RA, Peshu N, Endert E, et al. Glucose homeostasis in children with falciparum malaria: precursor supply limits gluconeogenesis and glucose production. J Clin Endocrinol Metab 1997; 82: 2514-2521.

154. White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983; 309: 61-66.

155. Sutton MG, Plappert T, Doubilet P. Relationship between placental blood flow and combined ventricular output with gestational age in normal human fetus. Cardiovasc Res 1991; 25: 603-608.

156. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg 1996; 55: 33-41.

157. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 1993; 6: 215262.

158. Fleming AF, Storey J, Molineaux L, Iroko EA, Attai ED. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979; 73: 161-172.

159. Genton B, D’Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008; 5: e127.

160. McKenzie FE, Smith DL, O’Meara WP, Forney JR, Magill AJ, Permpanich B, et al. Fever in patients with mixed-species malaria. Clin Infect Dis 2006; 42: 1713-1718.

161. Gupta B, Gupta P, Sharma A, Singh V, Dash AP, Das A. High proportion of mixed-species Plasmodium infections in India revealed by PCR diagnostic assay. Trop Med Int Health 2010; 15: 819-824.

162. Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, et al. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother 2008; 52: 1040-1045.

163. Mayxay M, Pukritrayakamee S, Chotivanich K, Imwong M, Looareesuwan S, White NJ. Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. Am J Trop Med Hyg 2001; 65: 588-592.

164. Campos Franco J, Llovo Taboada J, Lopez Rodriguez R, Mallo Gonzalez N, Cortizo Vidal S, Alende Sixto R. [Mixed infection due to Plasmodium falciparum and Plasmodium malariae: diagnostic usefulness of molecular methods]. An Med Interna 2008; 25: 149-150.

165. Mockenhaupt FP, Ulmen U, von Gaertner C, Bedu-Addo G, Bienzle U. Diagnosis of placental malaria. J Clin Microbiol 2002; 40: 306-308.

166. Seed CR, Cheng A, Davis TM, Bolton WV, Keller AJ, Kitchen A, et al. The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria. Vox Sang 2005; 88: 98-106.

167. Ministerio de la Protección Social República de Colombia. Cuadros de Indicadores Salud Pública, Tasa de incidencia de malaria en población a riesgo Bogota; 2009.

168. Trampuz A, Jereb M, Muzlovic I, Prabhu RM. Clinical review: Severe malaria. Crit Care 2003; 7: 315-323.

169. Freitas do Rosario AP, Muxel SM, Rodriguez- Malaga SM, Sardinha LR, Zago CA, Castillo- Mendez SI, et al. Gradual decline in malariaspecific memory T cell responses leads to failure to maintain long-term protective immunity to Plasmodium chabaudi AS despite persistence of B cell memory and circulating antibody. J Immunol 2008; 181: 8344-8355.

170. Chiodini PL, Hartley S, Hewitt PE, Barbara JA, Lalloo K, Bligh J, et al. Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang 1997; 73: 143-148.

171. Suh KN, Kain KC, Keystone JS. Malaria. CMAJ 2004; 170: 1693-1702.